|
|
|
Volumn 12, Issue 12, 2001, Pages 2-3
|
|
Fusion inhibitors: T-20 and T-1249.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
PEPTIDE FRAGMENT;
PEPTIDE T21;
ARTICLE;
CANADA;
CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MEMBRANE FUSION;
PHYSIOLOGY;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CANADA;
CLINICAL TRIALS;
FEMALE;
HIV;
HIV ENVELOPE PROTEIN GP41;
HIV INFECTIONS;
HUMANS;
MALE;
MEMBRANE FUSION;
PEPTIDE FRAGMENTS;
|
|
EID: 0035289055
PISSN: 11817186
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|